-
1
-
-
33749262441
-
Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-betadependent HIF-1alpha-mediated induction of CXCL12
-
Tabatabai G, Frank B, Mohle R, Weller M, Wick W. Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-betadependent HIF-1alpha-mediated induction of CXCL12. Brain 2006; 129: 2426-2435.
-
(2006)
Brain
, vol.129
, pp. 2426-2435
-
-
Tabatabai, G.1
Frank, B.2
Mohle, R.3
Weller, M.4
Wick, W.5
-
2
-
-
0035866813
-
Sublethal irradiation promotes migration and invasiveness of glioma cells: Implications for radiotherapy of human glioblastoma
-
Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 2001; 61: 2744-2750.
-
(2001)
Cancer Res
, vol.61
, pp. 2744-2750
-
-
Wild-Bode, C.1
Weller, M.2
Rimner, A.3
Dichgans, J.4
Wick, W.5
-
3
-
-
78651500461
-
Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide
-
Minniti G, Amelio D, Amichetti M, Salvati M, Muni R, Bozzao A et al. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother Oncol 2010; 97: 377-381.
-
(2010)
Radiother Oncol
, vol.97
, pp. 377-381
-
-
Minniti, G.1
Amelio, D.2
Amichetti, M.3
Salvati, M.4
Muni, R.5
Bozzao, A.6
-
4
-
-
60649106195
-
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis
-
Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vinals F et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 2009; 15: 220-231.
-
(2009)
Cancer Cell
, vol.15
, pp. 220-231
-
-
Paez-Ribes, M.1
Allen, E.2
Hudock, J.3
Takeda, T.4
Okuyama, H.5
Vinals, F.6
-
5
-
-
34347220473
-
Defining the role of mTOR in cancer
-
Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007; 12: 9-22.
-
(2007)
Cancer Cell
, vol.12
, pp. 9-22
-
-
Guertin, D.A.1
Sabatini, D.M.2
-
6
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
-
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307: 1098-1101.
-
(2005)
Science
, vol.307
, pp. 1098-1101
-
-
Sarbassov, D.D.1
Guertin, D.A.2
Ali, S.M.3
Sabatini, D.M.4
-
7
-
-
7944235758
-
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
-
Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6: 1122-1128.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 1122-1128
-
-
Jacinto, E.1
Loewith, R.2
Schmidt, A.3
Lin, S.4
Ruegg, M.A.5
Hall, A.6
-
9
-
-
17944377486
-
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
-
Neshat MS, Mellinghoff IK, Tran C, Stiles B, Thomas G, Petersen R et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci USA 2001; 98: 10314-10319.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 10314-10319
-
-
Neshat, M.S.1
Mellinghoff, I.K.2
Tran, C.3
Stiles, B.4
Thomas, G.5
Petersen, R.6
-
10
-
-
17944368972
-
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten/- mice
-
Podsypanina K, Lee RT, Politis C, Hennessy I, Crane A, Puc J et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten/- mice. Proc Natl Acad Sci USA 2001; 98: 10320-10325.
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 10320-10325
-
-
Podsypanina, K.1
Lee, R.T.2
Politis, C.3
Hennessy, I.4
Crane, A.5
Puc, J.6
-
11
-
-
3042823868
-
The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas
-
Chakravarti A, Zhai G, Suzuki Y, Sarkesh S, Black PM, Muzikansky A et al. The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 2004; 22: 1926-1933.
-
(2004)
J Clin Oncol
, vol.22
, pp. 1926-1933
-
-
Chakravarti, A.1
Zhai, G.2
Suzuki, Y.3
Sarkesh, S.4
Black, P.M.5
Muzikansky, A.6
-
12
-
-
33746637660
-
Current development of mTOR inhibitors as anticancer agents
-
Faivre S, Kroemer G, Raymond E. Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov 2006; 5: 671-688.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 671-688
-
-
Faivre, S.1
Kroemer, G.2
Raymond, E.3
-
13
-
-
33746807790
-
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas
-
Doherty L, Gigas DC, Kesari S, Drappatz J, Kim R, Zimmerman J et al. Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas. Neurology 2006; 67: 156-158.
-
(2006)
Neurology
, vol.67
, pp. 156-158
-
-
Doherty, L.1
Gigas, D.C.2
Kesari, S.3
Drappatz, J.4
Kim, R.5
Zimmerman, J.6
-
14
-
-
23944453425
-
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A North Central Cancer Treatment Group Study
-
Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, Boni J et al. Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 2005; 23: 5294-5304.
-
(2005)
J Clin Oncol
, vol.23
, pp. 5294-5304
-
-
Galanis, E.1
Buckner, J.C.2
Maurer, M.J.3
Kreisberg, J.I.4
Ballman, K.5
Boni, J.6
-
15
-
-
75049084471
-
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma
-
Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Friedman AH, Herndon 2nd JE et al. Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma. J Neurooncol 2010; 96: 219-230.
-
(2010)
J Neurooncol
, vol.96
, pp. 219-230
-
-
Reardon, D.A.1
Desjardins, A.2
Vredenburgh, J.J.3
Gururangan, S.4
Friedman, A.H.5
Herndon, J.E.6
-
16
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-466.
-
(2009)
Lancet Oncol
, vol.10
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
Van Den Bent, M.J.4
Taphoorn, M.J.5
Janzer, R.C.6
-
17
-
-
34548528069
-
Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma
-
Motzer RJ, Hudes GR, Curti BD, McDermott DF, Escudier BJ, Negrier S et al. Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma. J Clin Oncol 2007; 25: 3958-3964.
-
(2007)
J Clin Oncol
, vol.25
, pp. 3958-3964
-
-
Motzer, R.J.1
Hudes, G.R.2
Curti, B.D.3
McDermott, D.F.4
Escudier, B.J.5
Negrier, S.6
-
18
-
-
68949102180
-
Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma
-
Hess G, Herbrecht R, Romaguera J, Verhoef G, Crump M, Gisselbrecht C et al. Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. J Clin Oncol 2009; 27: 3822-3829.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3822-3829
-
-
Hess, G.1
Herbrecht, R.2
Romaguera, J.3
Verhoef, G.4
Crump, M.5
Gisselbrecht, C.6
-
19
-
-
0034901515
-
Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition
-
Dudkin L, Dilling MB. Cheshire PJ, Harwood FC, Hollingshead M, Arbuck SG et al. Biochemical correlates of mTOR inhibition by the rapamycin ester CCI-779 and tumor growth inhibition. Clin Cancer Res 2001; 7: 1758-1764.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1758-1764
-
-
Dudkin, L.1
Dilling, M.B.2
Cheshire, P.J.3
Harwood, F.C.4
Hollingshead, M.5
Arbuck, S.G.6
-
20
-
-
0035866358
-
Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/ medulloblastoma models as single agent and in combination chemotherapy
-
Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN et al. Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/ medulloblastoma models as single agent and in combination chemotherapy. Cancer Res 2001; 61: 1527-1532.
-
(2001)
Cancer Res
, vol.61
, pp. 1527-1532
-
-
Geoerger, B.1
Kerr, K.2
Tang, C.B.3
Fung, K.M.4
Powell, B.5
Sutton, L.N.6
-
21
-
-
0030831934
-
Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion
-
Sampson JH, Ashley DM, Archer GE, Fuchs HE, Dranoff G, Hale LP et al. Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion. Neurosurgery 1997; 41: 1365-1372.
-
(1997)
Neurosurgery
, vol.41
, pp. 1365-1372
-
-
Sampson, J.H.1
Ashley, D.M.2
Archer, G.E.3
Fuchs, H.E.4
Dranoff, G.5
Hale, L.P.6
-
22
-
-
0037200004
-
Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin
-
Park IH, Bachmann R, Shirazi H, Chen J. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. J Biol Chem 2002; 277: 31423-31429.
-
(2002)
J Biol Chem
, vol.277
, pp. 31423-31429
-
-
Park, I.H.1
Bachmann, R.2
Shirazi, H.3
Chen, J.4
-
23
-
-
32944457518
-
MTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
-
O'Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D et al. mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 2006; 66: 1500-1508.
-
(2006)
Cancer Res
, vol.66
, pp. 1500-1508
-
-
O'Reilly, K.E.1
Rojo, F.2
She, Q.B.3
Solit, D.4
Mills, G.B.5
Smith, D.6
-
24
-
-
62449266454
-
TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): Phospho-Ser2481 is a marker for intact mTOR signaling complex 2
-
Copp J, Manning G, Hunter T. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res 2009; 69: 1821-1827.
-
(2009)
Cancer Res
, vol.69
, pp. 1821-1827
-
-
Copp, J.1
Manning, G.2
Hunter, T.3
-
25
-
-
58649092475
-
MTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
-
Garcia-Martinez JM, Alessi DR. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 2008; 416: 375-385.
-
(2008)
Biochem J
, vol.416
, pp. 375-385
-
-
Garcia-Martinez, J.M.1
Alessi, D.R.2
-
26
-
-
66749132465
-
Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway
-
Hu W, Li F, Mahavadi S, Murthy KS. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway. Am J Physiol Cell Physiol 2009; 296: C1310-1320.
-
(2009)
Am J Physiol Cell Physiol
, vol.296
-
-
Hu, W.1
Li, F.2
Mahavadi, S.3
Murthy, K.S.4
-
27
-
-
78349245231
-
Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks
-
Sarkaria JN, Galanis E, Wu W, Dietz AB, Kaufmann TJ, Gustafson MP et al. Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks. Clin Cancer Res 2010; 16: 5573-5580.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 5573-5580
-
-
Sarkaria, J.N.1
Galanis, E.2
Wu, W.3
Dietz, A.B.4
Kaufmann, T.J.5
Gustafson, M.P.6
-
28
-
-
33644820339
-
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
-
Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006; 9: 157-173.
-
(2006)
Cancer Cell
, vol.9
, pp. 157-173
-
-
Phillips, H.S.1
Kharbanda, S.2
Chen, R.3
Forrest, W.F.4
Soriano, R.H.5
Wu, T.D.6
-
29
-
-
67649411967
-
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death
-
Ronellenfitsch MW, Brucker DP, Burger MC, Wolking S, Tritschler F, Rieger J et al. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death. Brain 2009; 132: 1509-1522.
-
(2009)
Brain
, vol.132
, pp. 1509-1522
-
-
Ronellenfitsch, M.W.1
Brucker, D.P.2
Burger, M.C.3
Wolking, S.4
Tritschler, F.5
Rieger, J.6
-
30
-
-
36148945617
-
R4 RGS proteins: Regulation of G-protein signaling and beyond
-
Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 2007; 116: 473-495.
-
(2007)
Pharmacol Ther
, vol.116
, pp. 473-495
-
-
Bansal, G.1
Druey, K.M.2
Xie, Z.3
-
31
-
-
70349473057
-
Regulator of G-protein signaling (RGS) proteins in cancer biology
-
Hurst JH, Hooks SB. Regulator of G-protein signaling (RGS) proteins in cancer biology. Biochem Pharmacol 2009; 78: 1289-1297.
-
(2009)
Biochem Pharmacol
, vol.78
, pp. 1289-1297
-
-
Hurst, J.H.1
Hooks, S.B.2
-
32
-
-
64849103757
-
G protein-coupled receptors stimulation and the control of cell migration
-
Cotton M, Claing A. G protein-coupled receptors stimulation and the control of cell migration. Cell Signal 2009; 21: 1045-1053.
-
(2009)
Cell Signal
, vol.21
, pp. 1045-1053
-
-
Cotton, M.1
Claing, A.2
-
33
-
-
0034128414
-
The regulator of G protein signaling family
-
De Vries L, Zheng B, Fischer T, Elenko E, Farquhar MG. The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 2000; 40: 235-271.
-
(2000)
Annu Rev Pharmacol Toxicol
, vol.40
, pp. 235-271
-
-
De Vries, L.1
Zheng, B.2
Fischer, T.3
Elenko, E.4
Farquhar, M.G.5
-
34
-
-
67651006540
-
Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4
-
Xie Y, Wolff DW, Wei T, Wang B, Deng C, Kirui JK et al. Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res 2009; 69: 5743-5751.
-
(2009)
Cancer Res
, vol.69
, pp. 5743-5751
-
-
Xie, Y.1
Wolff, D.W.2
Wei, T.3
Wang, B.4
Deng, C.5
Kirui, J.K.6
-
35
-
-
1542297687
-
Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility
-
Tatenhorst L, Senner V, Puttmann S, Paulus W. Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J Neuropathol Exp Neurol 2004; 63: 210-222.
-
(2004)
J Neuropathol Exp Neurol
, vol.63
, pp. 210-222
-
-
Tatenhorst, L.1
Senner, V.2
Puttmann, S.3
Paulus, W.4
-
36
-
-
3042604602
-
Regional expression of RGS4 mRNA in human brain
-
Erdely HA, Lahti RA, Lopez MB, Myers CS, Roberts RC, Tamminga CA et al. Regional expression of RGS4 mRNA in human brain. Eur J Neurosci 2004; 19: 3125-3128.
-
(2004)
Eur J Neurosci
, vol.19
, pp. 3125-3128
-
-
Erdely, H.A.1
Lahti, R.A.2
Lopez, M.B.3
Myers, C.S.4
Roberts, R.C.5
Tamminga, C.A.6
-
37
-
-
33745712929
-
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion
-
Ding J, Guzman JN, Tkatch T, Chen S, Goldberg JA, Ebert PJ et al. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat Neurosci 2006; 9: 832-842.
-
(2006)
Nat Neurosci
, vol.9
, pp. 832-842
-
-
Ding, J.1
Guzman, J.N.2
Tkatch, T.3
Chen, S.4
Goldberg, J.A.5
Ebert, P.J.6
-
39
-
-
33748746323
-
Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4)
-
Levitt P, Ebert P, Mirnics K, Nimgaonkar VL, Lewis DA. Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry 2004; 60: 534-537.
-
(2004)
Biol Psychiatry
, vol.60
, pp. 534-537
-
-
Levitt, P.1
Ebert, P.2
Mirnics, K.3
Nimgaonkar, V.L.4
Lewis, D.A.5
-
40
-
-
77956254304
-
Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins
-
Blazer LL, Roman DL, Chung A, Larsen MJ, Greedy BM, Husbands SM et al. Reversible, allosteric small-molecule inhibitors of regulator of G protein signaling proteins. Mol Pharmacol 2010; 78: 524-533.
-
(2010)
Mol Pharmacol
, vol.78
, pp. 524-533
-
-
Blazer, L.L.1
Roman, D.L.2
Chung, A.3
Larsen, M.J.4
Greedy, B.M.5
Husbands, S.M.6
-
42
-
-
79251575938
-
Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma
-
Pitter KL, Galban CJ, Galban S, Saeed-Tehrani O, Li F, Charles N et al. Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma. PloS One 2011; 6: e14545.
-
(2011)
PloS One
, vol.6
-
-
Pitter, K.L.1
Galban, C.J.2
Galban, S.3
Saeed-Tehrani, O.4
Li, F.5
Charles, N.6
-
43
-
-
52449131427
-
PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel
-
Yang L, Clarke MJ, Carlson BL, Mladek AC, Schroeder MA, Decker P et al. PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel. Clin Cancer Res 2008; 14: 3993-4001.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 3993-4001
-
-
Yang, L.1
Clarke, M.J.2
Carlson, B.L.3
Mladek, A.C.4
Schroeder, M.A.5
Decker, P.6
-
44
-
-
0032409396
-
A new method for the rapid and long term growth of human neural precursor cells
-
Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T et al. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 1998; 85: 141-152.
-
(1998)
J Neurosci Methods
, vol.85
, pp. 141-152
-
-
Svendsen, C.N.1
Borg, M.G.2
Armstrong, R.J.3
Rosser, A.E.4
Chandran, S.5
Ostenfeld, T.6
-
45
-
-
50849095153
-
Enzastaurininduced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL
-
Rieger J, Lemke D, Maurer G, Weiler M, Frank B, Tabatabai G et al. Enzastaurininduced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL. J Neurochem 2008; 106: 2436-2448.
-
(2008)
J Neurochem
, vol.106
, pp. 2436-2448
-
-
Rieger, J.1
Lemke, D.2
Maurer, G.3
Weiler, M.4
Frank, B.5
Tabatabai, G.6
-
46
-
-
4544341015
-
Linear models and empirical bayes methods for assessing differential expression in microarray experiments
-
Article3
-
Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:Article3.
-
(2004)
Stat Appl Genet Mol Biol
, vol.3
-
-
Smyth, G.K.1
-
47
-
-
0036081355
-
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
-
Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002; 30: 207-210.
-
(2002)
Nucleic Acids Res
, vol.30
, pp. 207-210
-
-
Edgar, R.1
Domrachev, M.2
Lash, A.E.3
-
48
-
-
65649089411
-
Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3- dioxygenase-1 via interferon-beta and protein kinase R
-
Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Koppel A et al. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3- dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 2009; 27: 909-919.
-
(2009)
Stem Cells
, vol.27
, pp. 909-919
-
-
Opitz, C.A.1
Litzenburger, U.M.2
Lutz, C.3
Lanz, T.V.4
Tritschler, I.5
Koppel, A.6
-
49
-
-
33745197969
-
BCL-xL: Timedependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells
-
Weiler M, Bahr O, Hohlweg U, Naumann U, Rieger J, Huang H et al. BCL-xL: timedependent dissociation between modulation of apoptosis and invasiveness in human malignant glioma cells. Cell Death Differ 2006; 13: 1156-1169.
-
(2006)
Cell Death Differ
, vol.13
, pp. 1156-1169
-
-
Weiler, M.1
Bahr, O.2
Hohlweg, U.3
Naumann, U.4
Rieger, J.5
Huang, H.6
-
50
-
-
77951625266
-
Updated response assessment criteria for high-grade gliomas: Response assessment in neuro-oncology working group
-
Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010; 28: 1963-1972.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1963-1972
-
-
Wen, P.Y.1
Macdonald, D.R.2
Reardon, D.A.3
Cloughesy, T.F.4
Sorensen, A.G.5
Galanis, E.6
|